Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Achievement of therapeutic targets in Mexican patients with diabetes mellitus.
Lavalle-González FJ, Chiquete E, de la Luz J, Ochoa-Guzmán A, Sánchez-Orozco LV, Godínez-Gutiérrez SA; IDMPS-3W collaborative group (Mexico). Lavalle-González FJ, et al. Endocrinol Nutr. 2012 Dec;59(10):591-8. doi: 10.1016/j.endonu.2012.07.005. Epub 2012 Nov 6. Endocrinol Nutr. 2012. PMID: 23137765
Prediction of Cardiovascular Disease by the Framingham-REGICOR Equation in the High-Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different Risk Strata.
Amor AJ, Serra-Mir M, Martínez-González MA, Corella D, Salas-Salvadó J, Fitó M, Estruch R, Serra-Majem L, Arós F, Babio N, Ros E, Ortega E; PREDIMED Investigators. Amor AJ, et al. J Am Heart Assoc. 2017 Mar 13;6(3):e004803. doi: 10.1161/JAHA.116.004803. J Am Heart Assoc. 2017. PMID: 28288977 Free PMC article. Clinical Trial.
Effectiveness of care provided by an itinerant community caregiver in reducing the burden and violence of family caregivers of impaired elderly in Rio de Janeiro, Brazil: A randomized clinical trial.
Lino VTS, Rodrigues NCP, Groisman D, Atie S, Camacho LAB, Perisse G. Lino VTS, et al. Among authors: camacho lab. PLoS One. 2024 Dec 5;19(12):e0309712. doi: 10.1371/journal.pone.0309712. eCollection 2024. PLoS One. 2024. PMID: 39636961 Free PMC article. Clinical Trial.
Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses.
Vianna CM, da Silva E Sá GR, Seid MVH, Camacho LAB, Xavier JR, da Gama VC, de Castro TDM, Dos Santos EAP, de Almeida CD, Cruz RLS, Siqueira M, Maia MLS, Ferroco CLV, de Araújo MF, Tort LFL, Caetano BC. Vianna CM, et al. Among authors: camacho lab. Mem Inst Oswaldo Cruz. 2024 Sep 9;119:e240094. doi: 10.1590/0074-02760240094. eCollection 2024. Mem Inst Oswaldo Cruz. 2024. PMID: 39258623 Free PMC article. Clinical Trial.
Duration of post-vaccination immunity to yellow fever in volunteers ten years after a dose-response study - A complementary study.
Vianna CM, Noronha TG, Camacho LAB, Andrade RC, de Souza Brum RC, Dos Santos EM, Aguiar DF, Dos Santos MLB, de Souza Cruz RL, de Lima SMB, de Souza Azevedo Soares A, Schwarcz WD, da Matta de Castro T, Xavier JR, da Conceição DA, Homma A, de Lourdes de Sousa Maia M. Vianna CM, et al. Among authors: camacho lab. Vaccine. 2024 Oct 24;42(24):126083. doi: 10.1016/j.vaccine.2024.06.050. Epub 2024 Jun 25. Vaccine. 2024. PMID: 38926068 Free PMC article.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Reis LR, Costa-Rocha IA, Abdala-Torres T, Campi-Azevedo AC, Peruhype-Magalhães V, Araújo MSS, Spezialli E, do Valle Antonelli LR, da Silva-Pereira RA, Almeida GG, Fernandes EG, Fantinato FFST, Domingues CMAS, Lemos MCF, Chieppe A, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Camacho LAB, de Lourdes de Sousa Maia M, de Noronha TG, Duault C, Rosenberg-Hasson Y, Teixeira-Carvalho A, Maecker HT, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine. Reis LR, et al. Among authors: camacho lab. Sci Rep. 2024 Apr 2;14(1):7709. doi: 10.1038/s41598-024-57645-3. Sci Rep. 2024. PMID: 38565882 Free PMC article.
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML; Collaborative Group for Studies of Yellow Fever Vaccine; Martins-Filho OA, do Antonelli LRDV. Abdala-Torres T, et al. Among authors: camacho lab. NPJ Vaccines. 2024 Mar 8;9(1):54. doi: 10.1038/s41541-024-00836-w. NPJ Vaccines. 2024. PMID: 38459059 Free PMC article.
Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics.
Motta E, Camacho LAB, Filippis AMB, Costa M, Pedro L, Cardoso SW, Souza MCO, Mendes YDS, Grinsztejn B, Coelho LE. Motta E, et al. Among authors: camacho lab. Braz J Infect Dis. 2024 Jan-Feb;28(1):103719. doi: 10.1016/j.bjid.2024.103719. Epub 2024 Feb 7. Braz J Infect Dis. 2024. PMID: 38341187 Free PMC article.
158 results